LY2599666
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LY2599666, covering 2019-09-23 to 2019-09-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD) [Phase 1]